HK1061530A1 - The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy. - Google Patents
The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy.Info
- Publication number
- HK1061530A1 HK1061530A1 HK04104522A HK04104522A HK1061530A1 HK 1061530 A1 HK1061530 A1 HK 1061530A1 HK 04104522 A HK04104522 A HK 04104522A HK 04104522 A HK04104522 A HK 04104522A HK 1061530 A1 HK1061530 A1 HK 1061530A1
- Authority
- HK
- Hong Kong
- Prior art keywords
- glucosamine
- acetyl
- manufacture
- supressing
- radiotherapy
- Prior art date
Links
- OVRNDRQMDRJTHS-UHFFFAOYSA-N N-acelyl-D-glucosamine Natural products CC(=O)NC1C(O)OC(CO)C(O)C1O OVRNDRQMDRJTHS-UHFFFAOYSA-N 0.000 title abstract 3
- OVRNDRQMDRJTHS-FMDGEEDCSA-N N-acetyl-beta-D-glucosamine Chemical compound CC(=O)N[C@H]1[C@H](O)O[C@H](CO)[C@@H](O)[C@@H]1O OVRNDRQMDRJTHS-FMDGEEDCSA-N 0.000 title abstract 3
- 229950006780 n-acetylglucosamine Drugs 0.000 title abstract 3
- 238000004519 manufacturing process Methods 0.000 title abstract 2
- 238000002512 chemotherapy Methods 0.000 title 1
- 238000001959 radiotherapy Methods 0.000 title 1
- 239000003814 drug Substances 0.000 abstract 2
- 230000000694 effects Effects 0.000 abstract 2
- 239000000126 substance Substances 0.000 abstract 2
- 238000002560 therapeutic procedure Methods 0.000 abstract 2
- 206010028980 Neoplasm Diseases 0.000 abstract 1
- 201000011510 cancer Diseases 0.000 abstract 1
- 230000002401 inhibitory effect Effects 0.000 abstract 1
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/7008—Compounds having an amino group directly attached to a carbon atom of the saccharide radical, e.g. D-galactosamine, ranimustine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Pharmacology & Pharmacy (AREA)
- Veterinary Medicine (AREA)
- Chemical & Material Sciences (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Medicinal Chemistry (AREA)
- Animal Behavior & Ethology (AREA)
- General Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Engineering & Computer Science (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Saccharide Compounds (AREA)
- Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| CN01104882A CN1131036C (zh) | 2001-02-28 | 2001-02-28 | N－乙酰－d－氨基葡萄糖在制备抑制放化疗副反应药物中的应用 |
| PCT/CN2002/000119 WO2002067946A1 (fr) | 2001-02-28 | 2002-02-28 | Utilisation de la n-acetyl-d-glucosamine dans la preparation de compositions pharmaceutiques utilisees dans la suppression des effets secondaires causes par la radiotherapie et la chimiotherapie |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| HK1061530A1 true HK1061530A1 (en) | 2004-09-24 |
Family
ID=4654071
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| HK04104522A HK1061530A1 (en) | 2001-02-28 | 2004-06-24 | The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy. |
Country Status (7)
| Country | Link |
|---|---|
| US (1) | US7037904B2 (de) |
| EP (1) | EP1374873B8 (de) |
| CN (1) | CN1131036C (de) |
| AT (1) | ATE293983T1 (de) |
| DE (1) | DE60203895T2 (de) |
| HK (1) | HK1061530A1 (de) |
| WO (1) | WO2002067946A1 (de) |
Families Citing this family (4)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| CN1210038C (zh) * | 2003-03-27 | 2005-07-13 | 中国人民解放军第三军医大学 | N－乙酰氨基葡萄糖在制备用于治疗毒物和药物中毒致脏器损伤的药物中的应用 |
| JP2007506645A (ja) * | 2003-09-17 | 2007-03-22 | 中国人民解放▲軍▼第三▲軍▼医大学 | 抗腫瘍および抗転移のための製剤の製造におけるｎ−アセチル−ｄ−グルコサミンの使用 |
| EP1909804B1 (de) * | 2005-08-03 | 2012-02-29 | National Cancer Center | Glucosamin und derivate davon als transglutaminase-inhibitoren zur verwendung in der behandlung von einer funktionsstörung des nervensystems |
| CN104267185B (zh) * | 2014-09-12 | 2016-05-18 | 范飞舟 | 检测肿瘤的试剂盒及其专用识别n-乙酰氨基葡萄糖的物质 |
Family Cites Families (8)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| US4216208A (en) * | 1978-07-31 | 1980-08-05 | Proter S.P.A. | N-Acyl derivatives of glucosamines having antitumor chemotherapeutic activity |
| US4710493A (en) * | 1984-08-14 | 1987-12-01 | Albert Landsberger | Therapeutic agent for the use in cancer treatment |
| CA1340994C (en) * | 1989-09-21 | 2000-05-16 | Rudolf Edgar Dr. Falk | Treatment of conditions and disease |
| US5229374A (en) * | 1992-01-28 | 1993-07-20 | Burton Albert F | Method for treatment of lower gastrointestinal tract disorders |
| WO1993018775A1 (en) | 1992-03-19 | 1993-09-30 | The University Of British Columbia | Method and composition for suppression of side effects of anti-inflammatory drugs |
| CN1067246C (zh) | 1996-12-27 | 2001-06-20 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗皮肤癣菌的药物中的应用 |
| CN1095366C (zh) * | 1996-12-27 | 2002-12-04 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗肠道疾病药物中的应用 |
| CN1067245C (zh) * | 1996-12-27 | 2001-06-20 | 中国人民解放军第三军医大学 | N－乙酰－d－氨基葡萄糖在制备治疗呼吸道疾病的药物中的应用 |
-
2001
- 2001-02-28 CN CN01104882A patent/CN1131036C/zh not_active Expired - Fee Related
-
2002
- 2002-02-28 EP EP02703474A patent/EP1374873B8/de not_active Expired - Lifetime
- 2002-02-28 WO PCT/CN2002/000119 patent/WO2002067946A1/zh not_active Application Discontinuation
- 2002-02-28 US US10/469,327 patent/US7037904B2/en not_active Expired - Fee Related
- 2002-02-28 DE DE60203895T patent/DE60203895T2/de not_active Expired - Lifetime
- 2002-02-28 AT AT02703474T patent/ATE293983T1/de not_active IP Right Cessation
-
2004
- 2004-06-24 HK HK04104522A patent/HK1061530A1/xx not_active IP Right Cessation
Also Published As
| Publication number | Publication date |
|---|---|
| EP1374873A4 (de) | 2004-08-11 |
| EP1374873B1 (de) | 2005-04-27 |
| ATE293983T1 (de) | 2005-05-15 |
| EP1374873A1 (de) | 2004-01-02 |
| US20040077596A1 (en) | 2004-04-22 |
| CN1372929A (zh) | 2002-10-09 |
| CN1131036C (zh) | 2003-12-17 |
| US7037904B2 (en) | 2006-05-02 |
| EP1374873B8 (de) | 2005-06-29 |
| DE60203895T2 (de) | 2005-09-29 |
| DE60203895D1 (de) | 2005-06-02 |
| WO2002067946A1 (fr) | 2002-09-06 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| IL267381A (en) | A pharmaceutical preparation containing dextromethorphan and quinidine for the treatment of nervous disorders | |
| TW200505483A (en) | New medicament compositions based on anticholinergically-effective compounds and β-mimetics | |
| TNSN05180A1 (en) | Liquid pharmaceutical formulations of palonosetron | |
| IL175714A0 (en) | Quinazolinone compounds as anticancer agents | |
| MXPA05013142A (es) | Compuestos de piridinio [1,2-a]pirimidin-4-ona como agentes anticancer. | |
| WO2004062604A3 (en) | Treatment of cancer with 2-deoxyglucose | |
| IL171607A (en) | Use of botulinum toxin for the treatment of sinusitis-induced headaches | |
| NZ540385A (en) | Use of 1-oxo-2-(2, 6-dioxopiperidin-3-yl)-4-methylisoindoline in the manufacture of a medicamnent for treatment of brain cancer | |
| MXPA03010121A (es) | Terapia de combinacion que utiliza anticuerpos anti-receptor de factor de crecimiento epidermico y agentes anti-hormonales. | |
| WO2007062093A3 (en) | Combination therapy for the treatment of cancer comprising a metalloprotease inhibitor | |
| IL155781A0 (en) | Effective antitumor treatments | |
| BG106171A (en) | Compositions and uses of et743 for treating cancer | |
| WO2003049694A3 (en) | Methods of therapy for non-hodgkin's lymphoma | |
| DE60222383D1 (de) | Medikament zur verabreichung von amifostin und verwandten wirkstoffen | |
| HK1061530A1 (en) | The use of n-acetyl-d-glucosamine in the manufacture of pharmaceutical useful for supressing side-effect of radiotherapy and chemotherapy. | |
| MXPA04005207A (es) | Metodos para tratar cancer utilizando un inhibidor de la farnesil proteina transferasa y agentes antineoplasticos. | |
| IL159770A0 (en) | Calcium salts with cytotoxic activity | |
| WO2002076393A3 (en) | Antiagionecic, antitumor, chemopreventative agents | |
| EP1390027A4 (de) | Zusammensetzung mit demethylcantharidin in kombination mit platinhaltigen antikrebsmitteln und ihre verwendung | |
| UA36756A (uk) | Спосіб лікування хворих із злоякісними пухлинами молочної залози | |
| UA26886C2 (uk) | Солі 1,3-діарил-4,5-поліметилеhімідазолію, що виявляють аhальгезуючу активhість |
Legal Events
| Date | Code | Title | Description |
|---|---|---|---|
| CHRG | Changes in the register |
Free format text: FROM THIRD MILITARY MEDICAL UNIVERSITY, CHINESE PEOPLE S LIBERATION ARMY, P.R. OF CHINA, BIO-WAVE INSTITUTE OF SUZHOU HI-TECH NEW DISTRICT CORPORATION, LTD |
|
| CHPA | Change of a particular in the register (except of change of ownership) | ||
| PC | Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee) |
Effective date: 20110228 |